Jennifer Buell's Net Worth
-$286 Thousand
Who is Jennifer Buell?
Jennifer Buell does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AGENUS INC, MiNK Therapeutics, Inc., and Protagenic Therapeutics, Inc.\new.
SEC CIK
Jennifer Buell's CIK is 0001711184
Past Insider Trading and Trends
2019 was Jennifer Buell's most active year for acquiring shares with 3 total transactions. Jennifer Buell's most active month to acquire stocks was the month of May. 2023 was Jennifer Buell's most active year for disposing of shares, totalling 6 transactions. Jennifer Buell's most active month to dispose stocks was the month of September. 2018 saw Jennifer Buell paying a total of $847,500.00 for 280,000 shares, this is the most they've acquired in one year. In 2023 Jennifer Buell cashed out on 2,235,800 shares for a total of $151,418.97, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGENUS INC (AGEN) Snapshot price: $0.6801
Chairman Executive Council
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +9.10% | 10.6K |
$5.49 | $58,177.53 | 127.09K |
Jun 15 - Jun 30
| |||
Form 4
| +226.72% | 80.84K |
$2.87 | $232,005.06 | 116.49K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +24.08% | 6.92K |
$3.53 | $25,295.37 | 35.66K |
Oct 9 - Dec 12
| |||
Form 4
| +17.96% | 4.38K |
$3.72 | $16,275.00 | 28.74K |
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
| -74.98% | -695.75K |
—
|
—
| 232.16K |
Oct 11
| |||
Form 4
| -13.80% | -148.55K |
$1.02 | -$151,418.97 | 927.91K |
Sep 29 - Oct 3
| |||
Form 4
| +182.75% | 695.75K |
—
|
—
| 1.08M |
Sep 27
| |||
Form 4
| +82.40% | 171.99K |
$2.32 | $399,016.80 | 380.71K |
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagenic Therapeutics, Inc.\new (PTIX) Snapshot price: $0.8312
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
| No matching records found | |||||||||